NIPH Clinical Trials Search

UMIN ID: UMIN000001574

Registered date:15/12/2008

Mie Study of Clopidogrel Low Responder in Atherothrombotic Disease Patients with/without Diabetes

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedAtherothrombotic disease
Date of first enrollment2008/11/01
Target sample size250
Countries of recruitmentJapan
Study typeObservational


Primary OutcomeTo develop the monitoring techniques of poor-responder for clopidgrel
Secondary OutcomeRelationship of SNIP of CYP2C19 Relationship of DM

Key inclusion & exclusion criteria

Age minimumNot applicable
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteria1) Patients before operation 2) Cerebral infraction without embolization from the heart 3) Taking following drugs, warfarin, thrombolytic agents, heparin, etc. anti-platelet drugs except aspirin, clopidogrel or cilostazol (e.g., sarpogrelate, diryridamole, EPA, etc.) 4) Not eligible determind by the responding physician

Related Information


public contact
Name Yuki Nishimura
Address 2-174, Edobashi, Tsu, MIE Japan
Telephone 059-231-5278
Affiliation Mie university hospital Clinical research support center
scientific contact
Name Masakatsu Nishikawa
Address 2-174, Edobashi, Tsu, MIE Japan
Telephone 059-231-5431
Affiliation Mie university faculty of medicine Institute of human research promotion and drug development